Journal of International Obstetrics and Gynecology ›› 2018, Vol. 45 ›› Issue (5): 500-503.

Previous Articles     Next Articles

The Assessment and Treatment Status of Lymph Node Metastasis in Endometrial Cancer

 LI Zhuang, LI Li   

  1. Department of Gynecologic Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning 530021, China
  • Received:2017-11-06 Revised:2018-05-17 Published:2018-10-15 Online:2018-10-18
  • Contact: LI Li,E-mail:lili@gxmu.edu.cn E-mail:lili@gxmu.edu.cn

Abstract: Endometrial carcinoma (EC) is one of the most common women malignant tumors. The prognosis of advanced EC is poor, and lymph node metastasis is an important factor affecting its prognosis. Lymphadenectomy in early EC is still controversial, adopting imaging examination, tumor markers,  sentinel lymph node biopsy to assess whether lymph node metastasis or not, decide lymph node dissection scope. Lymph node metastasis means the advanced EC, the treatment is comprehensive treatment model such as surgery, radiotherapy, chemotherapy and hormone therapy. Lymph node dissection has important implications for the prognosis, staging and postoperative treatment of EC. Surgical treatment of EC patients should follow the principle of individualization, develop a reasonable surgical plan, and determine whether lymph node dissection and its scope should be performed. Our purpose is mainly to focus on the assessment, treatment and prognosis related factors of EC lymph node metastasis for further discussion.

Key words: Endometrial neoplasms, Lymph nodes, Lymphatic metastasis, Lymphadenectomy, Prognosis